Log in
Enquire now
‌

US Patent 10995360 Use of aptamers in proteomics

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109953600
Patent Inventor Names
Clive Gavin Brown0
Koen Kas0
Sven Agnes Jan Eyckerman0
Date of Patent
May 4, 2021
0
Patent Application Number
164069030
Date Filed
May 8, 2019
0
Patent Citations
‌
US Patent 10316349 Use of aptamers in proteomics
Patent Citations Received
‌
US Patent 12116618 Use of aptamers in proteomics
0
‌
US Patent 11624083 Use of aptamers in proteomics
0
Patent Primary Examiner
‌
Jane J Zara
0
Patent abstract

The present invention is a method for measuring the amount of at least one molecule in a biological sample, the method comprising a) combining the sample, or a derivative thereof, with one or more aptamers and allowing one or more molecules in the sample to bind to the aptamer(s); b) separating bound from unbound molecules; and c) quantifying the molecule(s) bound to the or each aptamer, wherein quantification of the bound molecule(s) is carried out by sequencing at least part of the or each aptamer. Uses of and products derived from the method are also contemplated.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10995360 Use of aptamers in proteomics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.